Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22.

doi:10.1016/s0190-9622(94)70007-9

Back to search

Article

Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22.

Journal of the American Academy of Dermatology - 1 Jan 1994

Pellicano R, Ciavarella G, Lomuto M, Di Giorgio G

Abstract excerpt

BACKGROUND: Our observation of familial cases of fixed drug eruption (FDE) prompted us to consider a genetic predisposition to this disease. OBJECTIVE: Our purpose was to determine whether there is any association between FDE and any of the major histocompatibility complex class I or II alleles....

Topics

Adolescent
Adult
Aged
Child
Disease Susceptibility
Drug Eruptions
Family
Female
Feprazone
HLA-B Antigens
Humans
Male
Middle Aged
Phenotype
Skin Tests

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.